Treatment for alcoholic liver disease
酒精性肝病的治疗
基本信息
- 批准号:8000368
- 负责人:
- 金额:$ 23.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-01 至 2012-02-28
- 项目状态:已结题
- 来源:
- 关键词:AdoptedAlcohol consumptionAlcoholic HepatitisAlcoholic Liver DiseasesAlcoholic liver damageAmericanAnimal ModelAnimalsApoptosisBiochemicalBiologicalBiological AssayBiological ProcessBiologyBiotechnologyBlood VesselsCYP1A2 geneCYP2C9 geneCYP2D6 geneCYP3A4 geneCatabolismCause of DeathCellsCellular AssayChronicCicatrixCirrhosisClinicalClinical TrialsCollaborationsCollagenCountryCouplingCytochrome P450DataDevelopmentDiseaseDrug KineticsEnzymesFibrosisGene ExpressionGoalsGrantHepatitis C virusHepatocyteHepatocyte Growth FactorHistologyHuman ResourcesIn VitroIndustryInjury to LiverLaboratoriesLeadLegal patentLigationLiteratureLiverLiver CirrhosisLiver FibrosisLiver RegenerationLiver diseasesLungMeasuresMedicalMetabolismMicrosomesModelingMolecular ModelsMonitorMusOrganPaperPatientsPharmaceutical ChemistryPharmacologic SubstancePhasePortal PressurePreventionPrincipal InvestigatorPropertyPublishingPulmonary EmphysemaRadiation OncologyRattusRecombinantsResearchResearch PersonnelResortRetinoidsScientistScreening procedureSeriesSignal TransductionSmall Business Innovation Research GrantSmooth Muscle Actin Staining MethodStagingTestingTherapeuticTherapeutic UsesTimeTretinoinUnited StatesWorkbasebile ductclinically relevantconnective tissue growth factordesigndrug discoverydrug synthesiseffective therapyexpectationexperienceimprovedin vitro Assayin vivoin vivo Modelinhibitor/antagonistliver cell proliferationliver functionliver transplantationmedical schoolsmimeticsmolecular modelingmouse modelnovelpre-clinicalpreclinical studypreventproblem drinkerproduct developmentprogramspublic health relevanceresearch studyretinoic acid 4-hydroxylasesafety studysmall molecule
项目摘要
DESCRIPTION (provided by applicant): Liver fibrosis is a form of scar formation that is found in almost all patients with chronic injury to the liver. Over time it frequently progresses to cirrhosis, an end-stage lethal disease which is the seventh leading cause of death in the United States and afflicts hundreds of millions of people worldwide. Alcohol intake remains the most important cause of liver cirrhosis in Western countries. Alcoholic liver disease can be divided in various stages of development: (1) mild alcoholic liver injury, (2) steatosis, (3) alcoholic hepatitis, (4) alcoholic liver fibrosis and (5) cirrhosis. Although several pharmacological therapies have been tried in patients with alcoholic liver disease, none of the therapeutics so far has shown consistent improvement in the course of alcoholic liver damage and there remains a major unmet medical need for effective therapies. There is a significant body of evidence implicating a requirement for All Trans Retinoic Acid (ATRA) for normal liver function and in liver regeneration. ATRA administration can prevent and reverse the course of liver fibrosis in animal models. Several studies have shown that inhibition of certain cytochrome P450 enzymes in vivo can boost endogenous ATRA levels and result in retinoid-like activity in dermatological and oncological animal models. The cytochrome P450 enzyme retinoic acid 4-hydroxylase is thought to be the key enzyme involved ATRA catabolism. In our preliminary data, we show that an inhibitor of retinoic acid 4-hydroxylase shows activity in a mouse model of TAA-induced liver fibrosis in mice, thus establishing a novel proof of concept for their potential use as therapeutics for liver fibrosis. Our long-term goal is the development of small molecule inhibitors of retinoic acid 4-hydroxylase as potential therapeutics for alcoholic liver disease. The objective of this application is to identify such inhibitors and evaluate them in two clinically relevant animal models of liver fibrosis.
PUBLIC HEALTH RELEVANCE: Liver fibrosis is a form of scar formation that is found in almost all patients with chronic injury to the liver caused by sustained immoderate alcohol consumption. Over time it frequently progresses to cirrhosis, an end- stage lethal disease which is the seventh leading cause of death in the United States and afflicts hundreds of millions of people worldwide. There is no therapeutic that shows consistent improvement in the course of alcoholic liver damage and there remains a major unmet medical need for effective therapies. There is a significant body of evidence implicating a requirement for All Trans Retinoic Acid (ATRA) for normal liver function and in liver regeneration. We intend to develop of small molecule inhibitors of retinoic acid 4- hydroxylase that can elevate the body's ATRA levels as a potential therapeutic for alcoholic liver disease.
描述(由申请人提供):肝纤维化是一种疤痕形成形式,几乎所有患有慢性肝脏损伤的患者都会发现这种情况。随着时间的推移,它经常发展为肝硬化,这是一种终末期致命疾病,是美国第七大死因,困扰着全世界数亿人。在西方国家,酒精摄入仍然是导致肝硬化的最重要原因。酒精性肝病可分为不同的发展阶段:(1)轻度酒精性肝损伤,(2)脂肪变性,(3)酒精性肝炎,(4)酒精性肝纤维化和(5)肝硬化。尽管已经在酒精性肝病患者中尝试了几种药物疗法,但迄今为止没有一种疗法能够在酒精性肝损伤过程中显示出持续的改善,并且对有效疗法的医疗需求仍然未得到满足。有大量证据表明,正常肝功能和肝再生需要全反式视黄酸 (ATRA)。 ATRA 给药可以预防和逆转动物模型中的肝纤维化进程。多项研究表明,体内抑制某些细胞色素 P450 酶可以提高内源性 ATRA 水平,并在皮肤病学和肿瘤学动物模型中产生类视黄醇样活性。细胞色素 P450 酶视黄酸 4-羟化酶被认为是参与 ATRA 分解代谢的关键酶。在我们的初步数据中,我们表明,视黄酸 4-羟化酶抑制剂在 TAA 诱导的小鼠肝纤维化小鼠模型中显示出活性,从而为其潜在用作肝纤维化治疗药物建立了新的概念证明。我们的长期目标是开发视黄酸 4-羟化酶的小分子抑制剂作为酒精性肝病的潜在疗法。本申请的目的是鉴定此类抑制剂并在两种临床相关的肝纤维化动物模型中对其进行评估。
公众健康相关性:肝纤维化是一种疤痕形成形式,几乎所有因持续过量饮酒而导致肝脏慢性损伤的患者都会出现这种情况。随着时间的推移,它经常发展为肝硬化,这是一种终末期致命疾病,是美国第七大死因,困扰着全世界数亿人。目前还没有一种治疗方法能够持续改善酒精性肝损伤的过程,并且对于有效治疗的医疗需求仍然存在未得到满足的重大问题。有大量证据表明,正常肝功能和肝再生需要全反式视黄酸 (ATRA)。我们打算开发视黄酸 4-羟化酶的小分子抑制剂,它可以提高体内的 ATRA 水平,作为酒精性肝病的潜在治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bert J. W. M. Oehlen其他文献
Bert J. W. M. Oehlen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bert J. W. M. Oehlen', 18)}}的其他基金
Steroid 11β-hydroxylase inhibitor for Cushing's Syndrome
类固醇 11β-羟化酶抑制剂治疗库欣综合征
- 批准号:
9465756 - 财政年份:2017
- 资助金额:
$ 23.85万 - 项目类别:
PDGFR and KDR Inhibitors for Liver Fibrosis
PDGFR 和 KDR 肝纤维化抑制剂
- 批准号:
7801858 - 财政年份:2010
- 资助金额:
$ 23.85万 - 项目类别:
相似海外基金
The investigation of chronic alcohol consumption enhanced aging colon in elder mice and the mechanism of suppressed on aging colon tissues by sesame lignans continuous intake
长期饮酒促进老年小鼠结肠衰老的研究及持续摄入芝麻木脂素抑制结肠组织衰老的机制
- 批准号:
23K10904 - 财政年份:2023
- 资助金额:
$ 23.85万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of carcinogenesis and symptoms associated with alcohol consumption
致癌的分子机制和饮酒相关症状
- 批准号:
23K05734 - 财政年份:2023
- 资助金额:
$ 23.85万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Internal Sources of Minority Stress and Alcohol Consumption
少数群体压力和饮酒的内部根源
- 批准号:
10742318 - 财政年份:2023
- 资助金额:
$ 23.85万 - 项目类别:
Characterizing the Relationship Between Alcohol Consumption and Neuron-Derived Exosomal MicroRNA Cargo in an Adolescent-Young Adult Twin Cohort
青少年双胞胎队列中酒精消耗与神经元衍生的外泌体 MicroRNA 货物之间关系的表征
- 批准号:
10452928 - 财政年份:2022
- 资助金额:
$ 23.85万 - 项目类别:
Endocrine regulation of alcohol consumption and fear learning
饮酒和恐惧学习的内分泌调节
- 批准号:
10483780 - 财政年份:2022
- 资助金额:
$ 23.85万 - 项目类别:
The impact of friends sharing different modalities of alcohol-related social media content on alcohol consumption: A longitudinal examination of changes in content shared by social networks over time
朋友分享不同形式的酒精相关社交媒体内容对饮酒的影响:对社交网络分享内容随时间变化的纵向研究
- 批准号:
10534428 - 财政年份:2022
- 资助金额:
$ 23.85万 - 项目类别:
Cannabis' Impact on Alcohol Consumption: Integrating Laboratory and Ecological Momentary Assessment Methods
大麻对酒精消费的影响:整合实验室和生态瞬时评估方法
- 批准号:
10339931 - 财政年份:2022
- 资助金额:
$ 23.85万 - 项目类别:
Chronic alcohol consumption results in elevated Autotaxin levels that suppress anti-tumor immunity
长期饮酒会导致自分泌运动因子水平升高,从而抑制抗肿瘤免疫力
- 批准号:
10370159 - 财政年份:2022
- 资助金额:
$ 23.85万 - 项目类别:
Cannabis' Impact on Alcohol Consumption: Integrating Laboratory and Ecological Momentary Assessment Methods
大麻对酒精消费的影响:整合实验室和生态瞬时评估方法
- 批准号:
10595096 - 财政年份:2022
- 资助金额:
$ 23.85万 - 项目类别:
Technology-based assessments and intervention to reduce alcohol consumption and improve HIV viral suppression in the Florida Cohort
基于技术的评估和干预,以减少佛罗里达队列的饮酒量并改善艾滋病病毒抑制
- 批准号:
10707386 - 财政年份:2022
- 资助金额:
$ 23.85万 - 项目类别: